Current efforts in research of pleural mesothelioma-An analysis of the ClinicalTrials.gov registry
- PMID: 30268449
- DOI: 10.1016/j.lungcan.2018.07.007
Current efforts in research of pleural mesothelioma-An analysis of the ClinicalTrials.gov registry
Abstract
Objectives: Currently there are many uncertainties in the optimal treatment of malignant pleural mesothelioma (MPM), this is reflected in discrepancies between current guidelines. Our aim was to evaluate the current status of prospective interventional clinical trials within the ClinicalTrials.gov registry in MPM in order to predict a potential impact on MPM management in the next years.
Material and methods: The records of 263.832 clinical trials registered were searched in December 2017. Trials starting between 2005 and 2017 (n = 262) were selected for further manual review. Trials including other tumour entities or mesothelioma originating outside the pleura (n = 94) were excluded, as well as trials where the primary endpoint has already been published (n = 22).
Results: In total, 91 clinical trials were identified and selected for further analysis. Most trials had a single arm design, were in phase I, and were non-randomized. Academic centres were recorded as primary sponsors in the majority of trials (56%), followed by industry in 21%. Most studies investigated targeted (n = 42) or cytotoxic therapies (n = 39). Ten studies investigated different genetic therapies. In 67% of the trials (n = 61) targeted and/or cytotoxic therapies were involved. Treatments involving surgery were investigated in 12 trials (13%), radiotherapy in 10 trials (11%). Only five studies (6%) were phase 3 studies and one was a phase 2/3 study. Four of these five phase 3 trials investigated targeted therapies, while one trial investigated prophylactic radiotherapy of operative tracts.
Conclusions: Currently running trials in MPM are mostly in early phases and dominated by systemic therapies. Very few trials evaluate loco-regional therapeutic approaches. The current controversy surrounding the use of surgery and radiotherapy within multimodal therapy strategies will not be answered by these trials in the coming years.
Keywords: Chemotherapy; Clinical trials; Clinicaltrials.gov; Guidelines; Immunotherapy; Malignant pleural mesothelioma; Radiotherapy; Surgery.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Updates in the diagnosis and treatment of malignant pleural mesothelioma.Curr Opin Pulm Med. 2018 Jul;24(4):319-326. doi: 10.1097/MCP.0000000000000489. Curr Opin Pulm Med. 2018. PMID: 29553973 Review.
-
Immunotherapy for malignant pleural mesothelioma. Current status and future prospects.Am J Respir Cell Mol Biol. 2014 May;50(5):870-5. doi: 10.1165/rcmb.2013-0472TR. Am J Respir Cell Mol Biol. 2014. PMID: 24450537 Review.
-
Advances in treatment of mesothelioma.Expert Opin Pharmacother. 2016 Jun;17(9):1197-205. doi: 10.1080/14656566.2016.1176145. Epub 2016 Apr 21. Expert Opin Pharmacother. 2016. PMID: 27055148 Review.
-
[Anti-tumor immunotherapy in malignant pleural mesothelioma].Rev Mal Respir. 2018 Apr;35(4):465-476. doi: 10.1016/j.rmr.2017.07.025. Epub 2018 Feb 4. Rev Mal Respir. 2018. PMID: 29415822 Review. French.
-
Is there a role for immunotherapy in malignant pleural mesothelioma?Med Oncol. 2018 May 29;35(7):98. doi: 10.1007/s12032-018-1156-x. Med Oncol. 2018. PMID: 29845408 Review.
Cited by
-
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP.Target Oncol. 2022 Jul;17(4):407-431. doi: 10.1007/s11523-022-00900-2. Epub 2022 Jul 30. Target Oncol. 2022. PMID: 35906513 Free PMC article. Review.
-
Results of the Meso-ORIGINS feasibility study regarding collection of matched benign-mesothelioma tissue pairs by longitudinal surveillance.BMJ Open. 2023 Aug 8;13(8):e067780. doi: 10.1136/bmjopen-2022-067780. BMJ Open. 2023. PMID: 37553196 Free PMC article.
-
Individualized prediction of survival benefit from postoperative radiotherapy for patients with malignant pleural mesothelioma.Cancer Med. 2023 Jun;12(11):12452-12461. doi: 10.1002/cam4.5955. Epub 2023 Apr 19. Cancer Med. 2023. PMID: 37076977 Free PMC article.
-
Identification of genes and pathways involved in malignant pleural mesothelioma using bioinformatics methods.BMC Med Genomics. 2021 Apr 13;14(1):104. doi: 10.1186/s12920-021-00954-7. BMC Med Genomics. 2021. PMID: 33849532 Free PMC article.
-
Workshop summary: Potential usefulness and feasibility of a US National Mesothelioma Registry.Am J Ind Med. 2020 Feb;63(2):105-114. doi: 10.1002/ajim.23062. Epub 2019 Nov 19. Am J Ind Med. 2020. PMID: 31743489 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical